Chinese instructions for Carfilzomib for injection

1. Indications:

Carfilzomib (Carfilzomib) is mainly used to treat multiple myeloma (Multiple Myeloma), which is a malignant tumor that usually occurs in plasma cells in the bone marrow and is characterized by abnormal proliferation and accumulation in the skeletal system, leading to bone damage and abnormal protein production.

2. Mechanism of action:

Carfilzomib belongs to the proteasome inhibitor class of drugs, and its main mechanism of action is to inhibit the function of the proteasome. The proteasome is an important organelle responsible for protein degradation in cells. Carfilzomib blocks the normal operation of the proteasome, leading to the accumulation of proteins in cancer cells and ultimately inducing cancer cell death.

3. Pharmacology:

Carfilzomib is administered intravenously to ensure the drug is effectively delivered into the body. It is highly selective, targeting mainly cancer cells and reducing damage to healthy cells. The mechanisms by which drugs are metabolized and eliminated from the body are not fully understood, but their use usually requires the supervision of a medical professional.

4. Dosage and usage:

1.Carfilzomib is usually administered intravenously in a hospital or clinic by a medical professional.

2.The initial dose and treatment plan will vary based on the patient's weight, medical condition, severity of illness, and treatment goals.

3.A treatment cycle usually consists of multiple cycles, each lasting several weeks.

4.Doctors will regularly monitor the patient’s blood indicators to ensure treatment effectiveness and control of adverse reactions.

5.Dosage adjustments may be necessary to ensure optimal therapeutic efficacy and reduce adverse side effects.

5. Side effects:

Carfilzomib treatment may be associated with some side effects, including but not limited to:

1.Platelets are reduced, which may lead to bleeding and congestion problems.

2.Heart problems require regular heart monitoring.

3.Abnormal kidney function requires monitoring of kidney function.

4.Difficulty breathing, nausea, vomiting, fatigue and other common discomforts.

6. Warnings and precautions:

1.Patients should closely follow the doctor’s recommendations and receive regular examinations and monitoring.

2.Carfilzomib may have adverse effects on the heart and kidneys, so heart and kidney function require special attention.

3.Patients should follow their doctor's precautions to reduce the risk of infection and other discomfort.

.During treatment, patients should report any discomfort related to drug therapy to their physician.

7. Contraindications:

Carfilzomib may be contraindicated in the following circumstances:

1.Patients allergic to carfilzomib or its ingredients.

2.Pregnant and nursing women as carfilzomib may cause adverse effects on the fetus or infant.

3.Patients with severe heart problems or cardiovascular disease.

8. Drug interactions:

When using carfilzomib, patients need to inform their doctor about all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements, because some drugs may interact with carfilzomib, affecting its efficacy or increasing the risk of adverse reactions.

9. Medication for special groups:

1.Children: The safety and effectiveness of carfilzomib have not been established in children and therefore its use in the treatment of children is generally not recommended.

2.Elderly patients: For elderly patients, doctors may need to adjust the dose because drug metabolism may be affected by age.

3.Pregnant and lactating women: Carfilzomib may have adverse effects on the fetus or infant, so use during pregnancy or lactation is not recommended.

10. Listing and price situation:

Carfilzomib has been launched in China and is included in medical insurance. Patients can purchase it domestically at a price of around 8,000 to 9,000 yuan. Please consult the local hospital pharmacy for specific prices. In foreign countries, the original drug of carfilzomib is mainly available, and the cheaper version is the European version of the original drug, which costs around 5,000. And the medicinal ingredients and efficacy are the same as those of domestic original medicines.